Navigation Links
X-Change Corporation Signs Multi-Million Dollar Agreement for Multi-State Product Release Licensing, Medical Cannabis Dispensary Management, and Cultivation Consulting
Date:8/20/2013

COLORADO SPRINGS, Colo., Aug. 20, 2013 /PRNewswire/ -- The X-Change Corporation (NASDAQ OTC: XCHC), a U.S. Company specializing in cannabinoid formulation-based health and wellness solutions, entered into a multi-year, strategic growth agreement with Medicine Dispensing Systems, a wholly owned subsidiary of Medbox, Inc., a publicly traded company, to provide its scientific and clinical expertise for ten medical cannabis dispensaries and cultivation facilities in the states of Arizona, California, Illinois, Massachusetts, Nevada, and Washington State. 

This milestone agreement provides X-Change Corp with the real opportunity to develop premiere branding and to introduce the Company's proprietary cannabinoid-based products and formulations within each state's regulatory framework.

Dr. Dorothy Bray, President of X-Change Corporation, stated, "This agreement will allow X-Change Corp to introduce much needed scientific research and improved clinical management into dispensaries to benefit patients. Medbox represents the gold standard in pharmaceutical and alternative medication dispensing and will help us to employ best-in-industry practices and improve our focus on clinical management aspects, accompanied by the scientific documentation and research to monitor clinical progress of patients.  Our novel approach position will set us even further apart from our competitors."

Under the agreement, as a part of each dispensary build-out, X-Change Corp will brand the operations with a new image and employ a market-exclusive use of the patented Medbox system. Medbox technology and software allows for biometric patient and employee identification, internal documentation and tracking of dispensing services for internal accounting and compliance purposes, and secure inventory management and control.  In its efforts to enter the legal medical cannabis dispensary space, X-Change Corp expects to announce the signing of a significant dispensary management agreement in the very near term.

About The X-Change Corporation


The X-Change Corporation is currently developing new natural cannabinoid containing products based on innovative formulations to utilize the unique and potent benefits of the cannabis and hemp plants. Medicinal properties of cannabis and hemp have been known and applied for thousands of years. With the aid of scientific research, The X-Change Corporation is translating such knowledge into development of effective cannabinoid formulation-based health and wellness solutions as well as cosmeceutical, nutraceutical, and food brands throughout the world. The Company's health and wellness, nutritional, and cosmetics lines will address personal needs and will evolve with the introduction of new formulations and products, advancing the Company within the expanding multibillion-dollar global market.

Forward Looking Statements


This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as "anticipate," "seek," intend," "believe," "plan," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. X-Change Corp. does not undertake any duty nor does it intend to update the results of these forward-looking statements.

X-Change Corp. 
President

Dr. Dorothy Bray
info@xchangecorp.com
www.xchangecorp.com
+1.866.326.5595

Investment Inquiries

Robert Kane

CFO, Sr Vp of Business Development
rkane@xchangecorp.com
+1.561.420.4824

 


'/>"/>
SOURCE The X-Change Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Medbox Signs Multi-State Consulting Deal with X-Change Corporation
2. X-Change Corporation Launches Upgraded Version of Phytiva Website, As Company Targets Distribution of Phytiva Product Line in United States and Worldwide, Extracts and New Products in Europe
3. Ambit Biosciences Corporation Announces Second Quarter 2013 Operational Results
4. Dynasil Corporation of America Reports Third Quarter Fiscal 2013 Financial Results
5. Omeros Corporation Reports Second Quarter 2013 Financial Results
6. Celsion Corporation Reports Second Quarter 2013 Financial Results and Provides HEAT Study Update
7. Techne Corporation Releases Unaudited Fourth Quarter And Fiscal Year 2013 Results
8. DURECT Corporation Announces Second Quarter 2013 Financial Results and Update of Programs
9. Psychemedics Corporation Announces Top Revenue Quarter
10. Celsion Corporation to Hold Second Quarter 2013 Financial Results Conference Call on Thursday, August 8, 2013
11. Comprehensive Care Corporation Signs Agreement With A National Leader In Pharmacy Benefit Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... Feb. 21, 2017 Patient Monitoring ... are used to monitor physiological signs. These devices are ... monitors. Remote patient monitoring is one of the key ... equipment in the market. Hence, vendors are developing technologically ... applications, which can send test results on time and ...
(Date:2/21/2017)... The global infusion pumps market is estimated ... to 2021, to reach USD 10.84 billion by 2021 ... chronic diseases along with increasing geriatric population, increasing adoption ... increase in surgical procedural volumes, and rising applications of ... key factors driving the growth of this market. However, ...
(Date:2/21/2017)... , Feb. 21, 2017  Luminex Corporation (NASDAQ: ... of directors has authorized the initiation of a quarterly cash ... This initial cash dividend will be payable on April 14, ... business on March 24, 2017. The board ... quarterly cash dividend of $0.06 to holders of its common ...
Breaking Medicine Technology:
(Date:2/22/2017)... ... February 22, 2017 , ... Bellus ... the latest innovation in the delivery of Platelet Rich Plasma (PRP). PRP systems ... pain management, to accelerate tissue synthesis and provide a faster and more efficient ...
(Date:2/22/2017)... ... February 22, 2017 , ... Super-Sod will attend the Athens Home Show ... Georgia. , A shift from Super-Sod’s simple Athens Home Show booth of 2016, this ... grass seed plant manager Chris Roquemore constructed furniture from recycled pallet wood at the ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... threats. Yet with so many different solutions on the market, it is easy ... choices, Texas Premier Locksmith offers a complimentary security consultation. , Home ...
(Date:2/21/2017)... ... 2017 , ... Author Michèle Wolff has a passion for using food ... know all about it for optimal health. Wanting to share her knowledge to the ... and Wellness Solutions ” (published by Balboa Press AU). , This book inspires ...
(Date:2/21/2017)... ... February 21, 2017 , ... As recently as 2015, rhinoplasty was one ... Society of Plastic Surgeons. Some patients want to make a change in the appearance ... improve their breathing ability. The team at usrhinoplasty.org is expanding its article ...
Breaking Medicine News(10 mins):